EVM
SRDX

Eaton Vance Management’s Surmodics SRDX Stock Holding History

Eaton Vance Management’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-753
Closed -$36K – 2593
2021
Q4 		$36K Sell
753
-76
-9% -$3.83K ﹤0.01% 2237
2021
Q3 		$0 Sell
829
-8
-1% -$444 ﹤0.01% 2618
2021
Q2 		$45K Buy
837
+774
+1,229% +$42.5K ﹤0.01% 2189
2021
Q1 		$4K Buy
+63
New +$3.14K ﹤0.01% 2668

Other funds holding SRDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Eaton Vance Management's SRDX Position: Q1 2022 in Review

Eaton Vance Management sold out of Surmodics (SRDX) in Q1 2022, closing a stake of 753 shares — an estimated $36K sold.

Eaton Vance Management first reported a position in SRDX in Q1 2021 and held it in 4 quarters. The position peaked at $45K in Q2 2021. 135 funds tracked by Wall St. Rank hold SRDX as of Q1 2022.

  • Eaton Vance Management reported no remaining Surmodics position as of Q1 2022 after selling out during the quarter.
  • Eaton Vance Management sold 753 Surmodics shares in Q1 2022, an estimated $36K.
  • Eaton Vance Management first reported a position in Surmodics in Q1 2021 and held it in 4 quarters.
  • Eaton Vance Management's Surmodics position peaked at $45K in Q2 2021.
  • 135 funds tracked by Wall St. Rank held Surmodics as of Q1 2022.

Based on Eaton Vance Management's 13F filing for Q1 2022, filed 16 May 2022.